Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| AbbVie Inc. | 38,777 | reported | 27 Feb 2026 | tx 30+257,182−118,794 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 Feb 2026 | TAX_WITHHOLDING | AbbVie Inc. | 21,638 | 232.08 USD | |
| 18 Feb 2026 | GRANT_AWARD | AbbVie Inc. | 7,260 | 0.00 USD | |
| 18 Feb 2026 | GRANT_AWARD | AbbVie Inc. | 7,606 | 0.00 USD | |
| 18 Feb 2026 | GRANT_AWARD | AbbVie Inc. | 25,062 | 0.00 USD | |
| 18 Feb 2026 | GRANT_AWARD | AbbVie Inc. | 8,910 | 0.00 USD | |
| 18 Feb 2026 | GRANT_AWARD | AbbVie Inc. | 21,937 | 0.00 USD | deriv |
| 14 Mar 2025 | SALE | AbbVie Inc. | 17,644 | 212.34 USD | |
| 28 Feb 2025 | TAX_WITHHOLDING | AbbVie Inc. | 10,973 | 205.02 USD | |
| 13 Feb 2025 | GRANT_AWARD | AbbVie Inc. | 7,608 | 0.00 USD | |
| 13 Feb 2025 | GRANT_AWARD | AbbVie Inc. | 5,845 | 0.00 USD | |
| 13 Feb 2025 | GRANT_AWARD | AbbVie Inc. | 2,398 | 0.00 USD | |
| 13 Feb 2025 | GRANT_AWARD | AbbVie Inc. | 8,912 | 0.00 USD | |
| 13 Feb 2025 | GRANT_AWARD | AbbVie Inc. | 27,343 | 0.00 USD | deriv |
| 23 Feb 2024 | SALE | AbbVie Inc. | 14,140 | 177.44 USD | |
| 28 Feb 2024 | TAX_WITHHOLDING | AbbVie Inc. | 11,634 | 178.99 USD | |
| 23 Feb 2024 | EXERCISE | AbbVie Inc. | 14,140 | 61.36 USD | |
| 23 Feb 2024 | EXERCISE | AbbVie Inc. | 14,140 | 61.36 USD | deriv |
| 15 Feb 2024 | GRANT_AWARD | AbbVie Inc. | 2,398 | 0.00 USD | |
| 15 Feb 2024 | GRANT_AWARD | AbbVie Inc. | 3,146 | 0.00 USD | |
| 15 Feb 2024 | GRANT_AWARD | AbbVie Inc. | 11,800 | 0.00 USD | |
| 15 Feb 2024 | GRANT_AWARD | AbbVie Inc. | 8,912 | 0.00 USD | |
| 15 Feb 2024 | GRANT_AWARD | AbbVie Inc. | 31,520 | 0.00 USD | deriv |
| 01 Mar 2023 | SALE | AbbVie Inc. | 850 | 153.38 USD | |
| 28 Feb 2023 | TAX_WITHHOLDING | AbbVie Inc. | 12,683 | 154.28 USD | |
| 01 Mar 2023 | SALE | AbbVie Inc. | 15,092 | 153.06 USD |